GQD regulates the lipid metabolic route of sphingomyelin and glycerophospholipid, improves the anti-tumor effectiveness of ICIs, inhibits tumor cell immune escape, and works with PD-1 inhibitors by modulating the Wnt/β-catenin signaling pathway. Here, PDCD1 is linked to neoplasm.